ATTRACT trial concludes clot-busting drugs do not prevent long-term blood clot complications for most patients

Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis (ATTRACT Main Results) Summary:  This article, published in the New England Journal of Medicine, describes the main results and primary outcome of the landmark ATTRACT Trial. Citation:  Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis […]

The ATTRACT Study: Open for Patient Enrollment (Currently closed)

https://www.veindirectory.org/magazine/article/industry-updates/the-attract-study-open-for-patient-enrollmentThe ATTRACT Study: Open for Patient EnrollmentApril 1, 2015 by Suresh Vedantham, MD The ATTRACT (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis) Study, which may define the future of DVT treatment, is now OPEN to patient enrollment! This study will determine if new clot-busting treatments for patients with large blood clots of the […]

Interview with Vein Specialist Suresh Vedantham M.D.

https://www.veindirectory.org/magazine/article/featured-doctor/cover-story-vein-specialist-suresh-vedantham-m-dVein Specialist Suresh Vedantham M.D.April 1, 2015 Vein specialist Suresh Vedantham M.D., has spent most of his career studying the diagnosis and treatment of venous thromboembolism (VTE), deep-vein thrombosis (DVT) and pulmonary embolism (PE). Nearly 1 million Americans suffer from DVT, and 500,000 of them develop PE, which causes some 300,000 deaths. These conditions remain […]

Pivotal study of minimally invasive therapy improves care of DVT

https://www.sirweb.org/advocacy-and-outreach/media/news-release-archive/news-release-ATTRACT-Trial/ Pivotal study of minimally invasive therapy improves the care of patients with deep vein thrombosis NIH-sponsored ATTRACT Trial finds opportunities to reduce disability and enhance patient safety WASHINGTON (March 6, 2017)—The results of a prominent, National Institutes of Health (NIH)-sponsored study into the treatment of deep vein thrombosis (DVT) provide important guidance for physicians […]

Blood clot treatments subject of major trial

Blood clot treatments subject of major trial By Michael C. Purdy • September 24, 2008 A $10 million, government-funded, multicenter clinical trial of an aggressive treatment for blood clots in the leg — known as deep vein thrombosis (DVT) — will be led by School of Medicine researchers. About 250,000 U.S. patients are diagnosed with […]

$10M clinical trial tests new treatment for blood clots

https://www.eurekalert.org/pub_releases/2008-09/wuso-mc091208.phpPUBLIC RELEASE: 15-SEP-2008$10M clinical trial tests new treatment for blood clots in the legWASHINGTON UNIVERSITY SCHOOL OF MEDICINE St. Louis, Sept. 15, 2008 — A $10 million, government-funded, multicenter clinical trial of an aggressive treatment for blood clots in the leg known as deep vein thrombosis (DVT) will be led by researchers at Washington University […]

ATTRACT Main Results

“This article, published in the New England Journal of Medicine, describes the main results and primary outcome of the landmark ATTRACT Trial.” To view the archived PDF of the ATTRACT New England Journal of Medicine publication, please click the button below: